ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced subset data results for the Angio-Seal™ Evolution™ Vascular Closure Device ...
St. Jude Children's Research Hospital researchers have identified a subtype of the brain tumor medulloblastoma that is associated with improved survival of infants treated with less aggressive, ...
Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to print (Opens in new window) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback